1. Home
  2. SCNI vs SGLY Comparison

SCNI vs SGLY Comparison

Compare SCNI & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • SGLY
  • Stock Information
  • Founded
  • SCNI 2003
  • SGLY 2001
  • Country
  • SCNI Israel
  • SGLY United States
  • Employees
  • SCNI N/A
  • SGLY N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • SGLY
  • Sector
  • SCNI Health Care
  • SGLY
  • Exchange
  • SCNI Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • SCNI 3.2M
  • SGLY 3.9M
  • IPO Year
  • SCNI N/A
  • SGLY 2008
  • Fundamental
  • Price
  • SCNI $2.47
  • SGLY $1.03
  • Analyst Decision
  • SCNI
  • SGLY
  • Analyst Count
  • SCNI 0
  • SGLY 0
  • Target Price
  • SCNI N/A
  • SGLY N/A
  • AVG Volume (30 Days)
  • SCNI 1.1M
  • SGLY 67.2K
  • Earning Date
  • SCNI 08-14-2025
  • SGLY 08-26-2025
  • Dividend Yield
  • SCNI N/A
  • SGLY N/A
  • EPS Growth
  • SCNI N/A
  • SGLY N/A
  • EPS
  • SCNI N/A
  • SGLY N/A
  • Revenue
  • SCNI $658,000.00
  • SGLY $2,172,036.00
  • Revenue This Year
  • SCNI N/A
  • SGLY N/A
  • Revenue Next Year
  • SCNI N/A
  • SGLY N/A
  • P/E Ratio
  • SCNI N/A
  • SGLY N/A
  • Revenue Growth
  • SCNI N/A
  • SGLY N/A
  • 52 Week Low
  • SCNI $1.90
  • SGLY $0.54
  • 52 Week High
  • SCNI $8.92
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 49.52
  • SGLY 51.57
  • Support Level
  • SCNI $2.15
  • SGLY $1.02
  • Resistance Level
  • SCNI $2.70
  • SGLY $1.16
  • Average True Range (ATR)
  • SCNI 0.22
  • SGLY 0.08
  • MACD
  • SCNI 0.01
  • SGLY -0.01
  • Stochastic Oscillator
  • SCNI 32.99
  • SGLY 50.00

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: